{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:41:29Z","timestamp":1773063689148,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Motor neuron disease has been reported as a rare result of systemic cancers, likely related to an autoimmune effecter mechanism. These patients have been described as having a more rapid onset of symptoms than typical motor neuron disease. Few of these reports demonstrate an association of a cancer-related autoantibody and with motor neuron disease. We present a 54-year-old woman with infiltrating ductal carcinoma of the breast who later developed lower motor neuron disease and was found to have Purkinje cell autoantibodies type 1. The association of lower motor neuron disease as a consequence of breast cancer with this autoantibody profile has not been described previously. This report emphasizes the importance of considering a paraneoplastic syndrome in a patient with an uncommon presentation of motor neuron disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0b013e3181c50528","type":"journal-article","created":{"date-parts":[[2010,8,28]],"date-time":"2010-08-28T11:03:52Z","timestamp":1282993432000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Paraneoplastic Motor Neuron Disease Associated With Purkinje Cell Autoantibody Type 1"],"prefix":"10.1097","volume":"12","author":[{"given":"B Jane","family":"Distad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20240808","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1017\/S0317167100041974","article-title":"The distinctive clinical features of paraneoplastic sensory neuronopathy.","volume":"19","author":"Chalk","year":"1992","journal-title":"Can J Neurol Sci"},{"key":"R2-5-20240808","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.50.3.652","article-title":"Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.","volume":"50","author":"Lucchinetti","year":"1998","journal-title":"Neurology"},{"key":"R3-5-20240808","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann Neurol"},{"key":"R4-5-20240808","first-page":"238","article-title":"Neoplasia in patients with amyotrophic lateral sclerosis.","volume":"89","author":"Norris","year":"1964","journal-title":"Trans Am Neurol Assoc"},{"key":"R5-5-20240808","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/jnnp.2003.025171","article-title":"A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.","volume":"75","author":"Candler","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-5-20240808","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2004.01.008","article-title":"The spectrum of antineuronal autoantibodies in a series of neurological patients.","volume":"220","author":"Vianello","year":"2004","journal-title":"J Neurol Sci"},{"key":"R7-5-20240808","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0733-8619(05)70336-4","article-title":"Paraneoplastic neuromuscular syndromes.","volume":"15","author":"Levin","year":"1997","journal-title":"Neurol Clin"},{"key":"R8-5-20240808","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJM199006283222604","article-title":"Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.","volume":"322","author":"Furneaux","year":"1990","journal-title":"N Engl J Med"},{"key":"R10-5-20240808","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","article-title":"Autoantibodies associated with peripheral neuropathy.","volume":"22","author":"Quarles","year":"1999","journal-title":"Muscle Nerve"},{"key":"R11-5-20240808","first-page":"412","article-title":"Paraneoplastic anti-Purkinje and type 1 anti-neuronal nuclear autoantibodies bind selectively to central, peripheral and autonomic nervous system cells.","volume":"65","author":"Altermatt","year":"1991","journal-title":"Lab Invest"},{"key":"R12-5-20240808","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.","volume":"126","author":"Shamsili","year":"2003","journal-title":"Brain"},{"key":"R13-5-20240808","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-510X(76)90080-0","article-title":"The epidemiology of amyotrophic lateral sclerosis in Finland: a study based on the death certificates of 421 patients.","volume":"29","author":"Jokelainen","year":"1976","journal-title":"J Neurol Sci"},{"key":"R14-5-20240808","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.30.5.453","article-title":"Epidemiology of amyotrophic lateral sclerosis. 1. A case-control comparison based on ALS deaths.","volume":"30","author":"Kurtzke","year":"1980","journal-title":"Neurology"},{"key":"R15-5-20240808","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.md.0000076004.64510.ce","article-title":"Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.","volume":"82","author":"Rojas-Marcos","year":"2003","journal-title":"Medicine"},{"key":"R16-5-20240808","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/jnnp.2006.097774","article-title":"Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease.","volume":"78","author":"Stich","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17-5-20240808","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410410608","article-title":"Motor neuron syndromes in cancer patients.","volume":"41","author":"Forsyth","year":"1997","journal-title":"Ann Neurol"},{"key":"R18-5-20240808","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410400118","article-title":"Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma.","volume":"40","author":"Verma","year":"1996","journal-title":"Ann Neurol"},{"key":"R19-5-20240808","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00415-008-0550-2","article-title":"Focal paraneoplastic syndrome associated with small cell carcinoma of the lung.","volume":"255","author":"Tofaris","year":"2008","journal-title":"J Neurol"},{"key":"R20-5-20240808","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/WNL.53.4.852","article-title":"A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer.","volume":"53","author":"Ferracci","year":"1999","journal-title":"Neurology"},{"key":"R21-5-20240808","first-page":"445","article-title":"Paraneoplastic motor neuron disease.","volume":"56","author":"Rosenfeld","year":"1991","journal-title":"Adv Neurol"},{"key":"R22-5-20240808","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients.","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"R23-5-20240808","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/(SICI)1097-4598(199807)21:7<943::AID-MUS14>3.0.CO;2-R","article-title":"Paraneoplastic motor neuron disease with type 1 Purkinje cell antibodies.","volume":"21","author":"Khwaja","year":"1998","journal-title":"Muscle Nerve"},{"key":"R24-5-20240808","first-page":"962","article-title":"Paraneoplastic motor neuron disease and renal cell carcinoma: Improvement after nephrectomy.","volume":"960-","author":"Evans","year":"40","journal-title":"Neurology"},{"key":"R25-5-20240808","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1378\/chest.115.3.899","article-title":"A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma.","volume":"115","author":"Forman","year":"1999","journal-title":"Chest"},{"key":"R26-5-20240808","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00131402-201009000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T23:15:18Z","timestamp":1723158918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-201009000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0b013e3181c50528","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}